Product image of Fiasp Penfill (Insulin Aspart) supplied by GNH India

Fiasp Penfill

Active Ingredient:
Insulin Aspart
Origin:
EU

Fiasp Penfill (Insulin Aspart)

Fiasp Penfill is a rapid-acting insulin used to manage blood glucose levels in diabetes. This subcutaneous insulin aspart formulation is designed for flexible dosing with meals.

Manufacturer / TM Owner

Novo Nordisk A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Fiasp Penfill is primarily used for the management of diabetes mellitus in adults and children. It is a rapid-acting insulin that helps control blood sugar levels, especially around mealtimes. This insulin aspart formulation is often prescribed for individuals requiring precise glucose control. What is Fiasp Penfill used for? It is commonly used to manage both type 1 and type 2 diabetes, providing rapid onset and short duration of action.

Side Effects

  • Fiasp Penfill works quickly to lower blood sugar levels after meals. Common effects may include hypoglycemia, injection site reactions, and potential weight changes. Some users may experience fatigue or dizziness, particularly if blood sugar levels drop too low.

Precautions & Warnings

  • Fiasp Penfill should be handled with care to avoid contamination. It is important to store it properly and use it as directed by a healthcare provider. Always check the insulin for particles or discoloration before use. Individuals with a history of hypoglycemia should monitor their blood sugar levels closely.

Avoid Interactions

  • Fiasp Penfill may interact with other medications, including oral hypoglycemic agents and certain antihypertensive drugs. Alcohol consumption can also affect blood sugar levels and should be monitored. Always consult a healthcare provider before starting or stopping any medication while using Fiasp Penfill.

Frequently Asked Questions

Fiasp Penfill is used to manage blood glucose levels in individuals with diabetes, particularly around mealtimes.

Fiasp Penfill should be stored in the refrigerator between 36°F to 46°F (2°C to 8°C) and kept away from direct heat and light.

Common side effects may include hypoglycemia, injection site reactions, and potential weight changes.

Fiasp Penfill may interact with other diabetes medications, so it is important to consult a healthcare provider before combining treatments.

Fiasp Penfill is designed to start working rapidly, typically within 5 to 10 minutes after injection.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Insulin Aspart

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT